NFKB1 and B-cell chronic lymphocytic leukemia: B cell receptor (BCR) signaling has been validated as an essential factor in the pathogenesis of CLL (and other B cell malignancies like diffuse large B cell lymphoma), providing stimulation of critical pro-survival pathways like PI3K-AKT and NF-κB [116].